The company purchased additional entitlements for the areas of the business that we did not previously serve across a very ...

SurgeGraph, one of the leading AI writing tools, today announced the launch of SurgeGraph Vertex, featuring its latest ...

Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.

In addition, Vertex offers workflow management tools, role-based security, event logging, and data analytics. Its pre-built integration platform includes mapping data fields, business logic and ...

VRTX to report Q3 earnings, expected EPS $4.14 and $2.72B in revenue. Cramer calls it a buy, analysts see 22% upside. Stock ...

The best Shark vacuums offer a wide range of features. We tested customer favorites head-to-head; see our results and reviews ...

Vertex Minerals Limited (ASX:VTX) (OTCMKTS:VTXXF) is pleased to announce an update on the Reward <a target=_blank href= ...

(Reuters) - Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments. The drugmaker now expects ...

Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ETCompany ParticipantsJoe Crivelli - Vice President, ...

Hello and thanks for joining us to discuss Vertex Inc third quarter financial results. I'm Joe Crivelli, Vice President, Investor Relations, David DiStefano, our President and CEO and John Schwab. Our ...